drugset / Trial / NCT03041740

Fluid Filled Lung Oxygenation Assistance Trial

NCT03041740

RandomizedParallel-groupOpen-labelTreatment

Summary

The primary study objective is to assess the safety and feasibility of perfluorooctylbromide (PFOB) partial liquid ventilation (PLV) in infants with severe Bronchopulmonary Dysplasia (BPD).

Timeline

Start
2017-06-27
Primary completion
2019-06-10
Completion
2019-06-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Perflubron Other / unclassified 2.5 unknown Other